Latest Breaking News On - Published april - Page 1 : comparemela.com

Tirzepatide Significantly Reduces Weight in Patients with OSA

New analysis from SURMOUNT-1 support the use of GLP-1/GIP agonist tirzepatide to reduce weight in patients with OSA and obesity/overweight.

Houston
Texas
United-states
Ron-grunstein
Circadian-research-group
Woolcock-institute
Eli-lilly-sponsored
Associated-professional-sleep-societies
Tout-tirzepatide
Weight-loss
Published-april

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Switzerland
Paris
France-general
France
Texas
United-states
Chicago
Illinois
Lugano

4 Genius Gems To Boost That Credit Score

Delinquent payments and collections can have a major negative impact on a credit score. Here's how you can avoid that trap.

Christian-annice
Equifax
Gems-to-boost-that-credit
Published-april

Measles Outbreak Control: CDC's Dynamic Modeling and Mass Vaccination Strategies

Measles Outbreak Control: CDC's Dynamic Modeling and Mass Vaccination Strategies
infectioncontroltoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infectioncontroltoday.com Daily Mail and Mail on Sunday newspapers.

Illinois
United-states
Chicago
Patriciaa-stinchfield
National-foundation-for-infectious-diseases
Adobe-stock
National-foundation
Infectious-diseases
How-complacency-associated-with-immunizations
Published-february
Time-use

Kevin Peterson, MD, MPH: Incretin Therapy's Potential

With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.

United-states
Houston
Texas
American
Kevin-peterson
Campbellp-semaglutide
American-diabetes-association
American-academy-of-physician-associates
University-of-minnesota
Editorial-advisory-board
American-academy
Physician-associates